A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1999
12/23/1999	WO1999065933A1 Novel cyclosporins
12/23/1999	WO1999065920A1 Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems
12/23/1999	WO1999065898A1 Imidazolyl derivatives
12/23/1999	WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999	WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
12/23/1999	WO1999065871A2 Thiolesters and uses thereof
12/23/1999	WO1999065870A2 Sulfonamide inhibitors of aspartyl protease
12/23/1999	WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999	WO1999065530A1 NrdD
12/23/1999	WO1999065522A1 Hla binding peptides and their uses
12/23/1999	WO1999065518A2 Lt and ct in parenteral immunization methods against helicobacter infection
12/23/1999	WO1999065513A2 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999	WO1999065511A2 Composition and method for treatment of pseudomonas infection
12/23/1999	WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999	WO1999065483A1 Mycobacterial inhibitors
12/23/1999	WO1999065466A1 Temperature-sensitive liposomal formulation
12/23/1999	WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999	WO1999065310A1 Il-8 receptor antagonists
12/23/1999	WO1999053960A3 Enhancing immune responses to genetic immunization by using a chemokine
12/23/1999	WO1999053043A3 Herpes simplex virus latency associated transcript polypeptides
12/23/1999	WO1999051741A3 Lyst protein complexes and lyst interacting proteins
12/23/1999	WO1999049881A3 Application of hsp70 proteins
12/23/1999	WO1999045098A3 Delivery or proteins into eukaryotic cells with recombinant yersinia
12/23/1999	DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999	CA2335487A1 Lt and ct in parenteral immunization methods against helicobacter infection
12/23/1999	CA2335464A1 Novel thiolesters and uses thereof
12/23/1999	CA2335435A1 Imidazolyl derivatives
12/23/1999	CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999	CA2335293A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999	CA2335292A1 Il-8 receptor antagonists
12/23/1999	CA2335184A1 Cyclic somatostatin analogs
12/23/1999	CA2334165A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999	CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999	CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999	CA2331880A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999	CA2331834A1 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999	CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999	CA2330824A1 Hla binding peptides and their uses
12/23/1999	CA2330667A1 Mycobacterial inhibitors
12/23/1999	CA2330210A1 Proteasomal activity
12/23/1999	CA2329689A1 Composition and method for treatment of pseudomonas
12/22/1999	EP0965639A1 Attenuated pestiviruses
12/22/1999	EP0965594A2 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein
12/22/1999	EP0964921A1 Novel streptococcal ers
12/22/1999	EP0964856A1 Bicyclic amino acids
12/22/1999	EP0964699A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF
12/22/1999	EP0964697A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
12/22/1999	EP0964693A1 Novel bacteriocins, transport and vector system and method of use thereof
12/22/1999	EP0964691A1 Use of conantokins
12/22/1999	EP0964689A1 Recombinant vaccine for diseases caused by encapsulated organisms
12/22/1999	EP0964687A1 Pharmaceutical compositions with antimicrobial activity
12/22/1999	EP0964617A1 Structure-based rational design of compounds to inhibit papillomavirus infection
12/22/1999	EP0758312B1 Substituted fused and bridged bicyclic compounds as therapeutic agents
12/22/1999	CN1239547A Pharmaceutical grade botanical drugs
12/22/1999	CN1239427A Use of mupirocin for manufacture of medicament for treatment of bacterial infections associated with colonisation of nasopharynx by pathogenic organisms
12/21/1999	US6005103 Pyrone derivatives as protease inhibitors and antiviral agents
12/21/1999	US6005090 Treatment and prevention of helicobacter infection
12/21/1999	US6005075 Purification; use in antitumor and/or antiviral treatment
12/21/1999	US6004987 Use of ligands which are specific for RXR receptors
12/21/1999	US6004978 Methods of treating cancer with aromatic nitro and nitroso compounds and their metabolites
12/21/1999	US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999	US6004968 Viricides; free of ethylenediaminetetraacetic acid and ethanol; preservative efficacy
12/21/1999	US6004799 Recombinant live feline immunodeficiency virus and proviral DNA vaccines
12/21/1999	US6004764 Screening methods for potential therapeutic agents which regulate the growth of m. tuberculosis; method for identifying genes of m. tuberculosis which are regulated by a sigma factor of m. tuberculosis
12/21/1999	US6004563 Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
12/21/1999	US6004562 Outer membrane protein B1 of Moraxella catarrhalis
12/21/1999	US6004560 Obtaining a liquid by boiling bupleurum scorzonerifolium willd, radix lastidis indigotica and folium lastidis for a long time in water, and then mixing the liquid thus obtained with vitamin c
12/21/1999	US6004557 Variants of human papillomavirus antigens
12/21/1999	US6004556 Staphylococcus aureus RSBU-1
12/21/1999	US6004551 Lactobacillus, skim milk, lactobacillus growth factor (lgf) and lactobacillus compositions which adhere to biomaterials, intestinal, vaginal and uroepithelial cells, to resist the action of certain anti-microbial agents
12/21/1999	US6004354 IceA gene and related methods
12/21/1999	CA2091557C Intestine colonizing lactobacilli
12/21/1999	CA2082951C Pulmonary administration of granulocyte colony stimulating factor
12/21/1999	CA2065287C New hcv isolates
12/21/1999	CA1340856C N-phosphonylmethoxyalkyl pyrimidines and purines and therapeutic application thereof
12/16/1999	WO1999064633A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999	WO1999064604A2 Attenuated pestiviruses
12/16/1999	WO1999064571A1 Interferon inducing genetically engineered attenuated viruses
12/16/1999	WO1999064570A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999	WO1999064464A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
12/16/1999	WO1999064462A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
12/16/1999	WO1999064442A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999	WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999	WO1999064420A1 β-CARBOLINE COMPOUNDS
12/16/1999	WO1999064419A1 Pyrrole derivatives, preparation method and pharmaceutical compositions containing same
12/16/1999	WO1999064417A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999	WO1999064416A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999	WO1999064405A1 Crystalline efavirenz
12/16/1999	WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999	WO1999064400A1 INHIBITORS OF p38
12/16/1999	WO1999064068A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999	WO1999064067A2 Vaccine
12/16/1999	WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999	WO1999064051A1 Novel antibacterial compounds
12/16/1999	WO1999064049A1 Novel antibacterial agents
12/16/1999	WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999	WO1999064047A1 Novel antiviral compounds
12/16/1999	WO1999064040A1 Novel polyene macrolide compounds and uses
12/16/1999	WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses

1 ... 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 ... 1798